Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR long-term extension in malignant tumor-related pain
2009-013291-46Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tapentadol in cancer pain, sponsored by Grünenthal GmbH. Primary endpoint: Number of subjects with adverse events. Started Jun 2010; status: completed.
02
Drugs
tapentadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2009-013291-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013291-46.